(Bloomberg) — Moderna Inc. joins the S&P 500 on Wednesday as the index’s the best performing stock this year — by a mile.
The move caps the drugmaker’s transformation from an early-stage biotech to a vaccine maker supplying Covid shots to the world. With a gain of more than 180% so far in 2021, Moderna’s share performance tops the index’s existing leader, L Brands Inc., which has risen about 100%.
In the runup to its inclusion in the U.S. benchmark, Moderna’s stock has made fresh…
Source link
